Y
Yina Li
Researcher at Harvard University
Publications - 3
Citations - 764
Yina Li is an academic researcher from Harvard University. The author has contributed to research in topics: LGR5 & Stem cell marker. The author has an hindex of 3, co-authored 3 publications receiving 632 citations. Previous affiliations of Yina Li include Beth Israel Deaconess Medical Center & Vanderbilt University Medical Center.
Papers
More filters
Journal ArticleDOI
The Pan-ErbB Negative Regulator Lrig1 Is an Intestinal Stem Cell Marker that Functions as a Tumor Suppressor
Anne E. Powell,Yang Wang,Yina Li,Emily J. Poulin,Anna L. Means,Mary Kay Washington,James N. Higginbotham,Alwin M. Juchheim,Nripesh Prasad,Shawn Levy,Yan Guo,Yu Shyr,Bruce J. Aronow,Kevin M. Haigis,Jeffrey L. Franklin,Robert J. Coffey,Robert J. Coffey +16 more
TL;DR: Light is shed on the relationship between proliferative and quiescent intestinal stem cells and a model in which intestinal stem cell quiescence is maintained by calibrated ErbB signaling with loss of a negative regulator predisposing to neoplasia is supported.
Journal ArticleDOI
Tissue-Specific Oncogenic Activity of KRASA146T
Emily J. Poulin,Emily J. Poulin,Asim K. Bera,Jia Lu,Yi Jang Lin,Yi Jang Lin,Samantha Dale Strasser,Samantha Dale Strasser,Joao A. Paulo,Tannie Q. Huang,Carolina Morales,Wei Yan,Joshua Cook,Joshua Cook,Jonathan A. Nowak,Douglas K. Brubaker,Douglas K. Brubaker,Douglas K. Brubaker,Brian A. Joughin,Christian W. Johnson,Christian W. Johnson,Rebecca A. Destefanis,Rebecca A. Destefanis,Phaedra C. Ghazi,Phaedra C. Ghazi,Sudershan R. Gondi,Thomas E. Wales,Roxana E. Iacob,Lana Bogdanova,Jessica J. Gierut,Jessica J. Gierut,Yina Li,Yina Li,John R. Engen,Pedro A. Perez-Mancera,Benjamin S. Braun,Steven P. Gygi,Douglas A. Lauffenburger,Kenneth D. Westover,Kevin M. Haigis,Kevin M. Haigis +40 more
TL;DR: It is demonstrated that the selection for specific KRAS mutants in human cancers from different tissues is due to their distinct signaling properties, demonstrating that context-dependent variations in signaling downstream of differentKRAS mutants drive the KRAS mutational pattern seen in cancer.
Journal ArticleDOI
Using a new Lrig1 reporter mouse to assess differences between two Lrig1 antibodies in the intestine.
Emily J. Poulin,Anne E. Powell,Yang Wang,Yina Li,Jeffrey L. Franklin,Robert J. Coffey,Robert J. Coffey +6 more
TL;DR: It is concluded thatAnti-Lrig1-R&D appears to recognize all Lrig1(+) cells, while anti-L rig1-VU recognizes a subpopulation of Lrig2(+) cells.